Oncogene expression and microvessel count in recurrent and nonrecurrent stage Ib squamous cell carcinoma of the cervix

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 44, Issue 6, 1999, Pages 493-496

  Hove, Maxwell G M ^a   Dinh, Tung V ^a   Hannigan, Edward V ^a   Lucci III, Joseph A ^a   Chopra, Vimlarani ^a   Smith, Edward R ^a   To, Tonia ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN P53;

ADULT; ARTICLE; CANCER RECURRENCE; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROCIRCULATION; ONCOGENE; ONCOGENE C ERB; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TUMOR VASCULARIZATION; UTERINE CERVIX CARCINOMA;

ADULT; CARCINOMA, SQUAMOUS CELL; FEMALE; GENE EXPRESSION; GENES, P53; HUMANS; HYSTERECTOMY; MICROCIRCULATION; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; ONCOGENES; PROGNOSIS; RADIOTHERAPY; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; UTERINE CERVICAL NEOPLASMS;

EID: 0033050181     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Srivastava A, Laidler P, Davies RP, et al: The prognostic significance of tumor vascularity in intermediate thickness (0.76-4.0 mm thick) skin melanoma: A quantitative histologic study. Am J Pathol 1988;133:419-423
2. Weidner N, Semple JP, Welch WR, et al: Tumor angiogenesis and metastasis: Correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8
3. Macchiarini P, Fontaini G, Hardin MJ, et al: Relation of neovasculature to metastasis of non-small cell lung cancer. Lancet 1992;340:145-146
4. Weidner N, Carrol PR, Flax J, et al: Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 1993;143:401-409
5. Maeda K, Chung YS, Takatsuka S, et al: Tumor angiogenesis as a predictor of recurrence in gastric carcinoma. J Clin Oncol 1995;13:477-481
6. Wiggins DL, Granai CO, Steinhoff MM, et al: Tumor angiogenesis as a prognostic factor in cervical carcinoma. Gynecol Oncol 1995;56:353-356
7. Abulafia O, Triest W, Shere DM, et al: Angiogenesis in endometrial hyperplasias and Stage I endometrial carcinoma. Obstet Gynecol 1995;86:479-485
8. Dinh TV, Hannigan EV, Smith ER, et al: Tumor angiogenesis as a predictor of recurrence in Stage Ib squamous cell carcinoma of the cervix. Obstet Gynecol 1996;87:751-754
9. Miettinen M: Immunohistochemistry in tumor diagnosis. Ann Med 1993;25:221-223
10. Weidner N: Tumor angiogenesis: Review of current applications in tumor prognostication. Semin Diagn Pathol 1993;10: 302-313
11. Stone CH, Lynch EF, Linden MD, et al: Immunocytochemical evaluation of proliferating cell nuclear antigen, Ki-67 (MIB-1) and p53 in predicting survival of primary and metastatic malignant melanomas. Appl Immunohistochem 1996;4:25-33
12. Costa MJ, Walls J, Trelford JD: C-erbB-2 oncoprotein overexpression in uterine cervix carcinoma with glandular differentiation. Am J Clin Pathol 1995;104:634-642
13. Langlois NEI, Skinner L, Miller ID: C-erbB-2 in cervical carcinoma (lett). Am J Clin Pathol 1996;106:556
14. Cirisano FD, Karlan BY: Role of HER-2/neu in gynecologic malignancies. Contemp Ob/Gyn 1996;41:49-75
15. Mosnier JF, Perret AG, Vindimian M, et al: An immunohistochemical study of the simultaneous expression of bcl-2 and p53 oncoproteins in epithelial tumors of the colon and rectum. Arch Pathol Lab Med 1996;120:654-659
16. Hamelin R, Laurent-Puig L, Olschwang S, et al: Association of p53 mutations with short survival in colorectal cancer. Gastroenterology 1994;106:42-48